Lifecore Biomedical to be Added to Nasdaq Biotech Index

Group 1 - Lifecore Biomedical, Inc. is set to be added to the Nasdaq Biotech Index effective December 22, 2025, as part of the annual reconstitution of the Nasdaq indexes [1] - The Nasdaq Biotechnology Index tracks the performance of Nasdaq-listed securities classified as biotechnology or pharmaceutical, calculated under a modified capitalization-weighted methodology [2] - Companies must meet specific eligibility requirements, including minimum market capitalization and average daily trading volume, to be included in the Nasdaq Biotechnology Index [2] Group 2 - Lifecore Biomedical is a fully integrated contract development and manufacturing organization (CDMO) specializing in the development, fill, and finish of sterile injectable pharmaceutical products [3] - The company has over 40 years of expertise in manufacturing premium, injectable-grade hyaluronic acid and partners with global and emerging biopharmaceutical and biotechnology companies [3]